MARATTO

article · Scientific Reports

New inorganic inhibitors derived from cefotaxime to enhance corrosion resistance of mild steel in 3% NaCl

20248 citationsOpen accessSuez University

Abstract

Abstract To overcome the threat of corrosion and its cost, a new Schiff base was prepared and utilized to synthesize inorganic inhibitors to enhance corrosion resistance and reduce current density. The Schiff base was obtained from the interaction of cefotaxime with acetylacetone, while 1 H NMR and IR spectra were used to confirm the preparation. Moreover, Fe III , Co II , Ni II and Cu II metal salts were reacted with the Schiff base to give the corresponding complexes. Meanwhile, the non-ionic behavior of the observed complexes in solutions was proved from the conductance results. In addition, the octahedral geometry and the postulated structure of complexes were determined from CHNM%, IR spectroscopy, UV-visible spectra, and TGA analysis. Also, the energy of molecular orbitals (HOMO and LUMO) and other quantum mechanics parameters were calculated using the DFT method. The observed results indicated the reactivity of metal complexes and their ability to donate electrons more than the Schiff base. Furthermore, the corrosion rate of a steel sample under various concentrations of inhibitors was calculated by a potentiodynamic polarization test. The obtained data displayed that metal complexes declined the corrosion rate more than the Schiff base; therefore, the binding between the metal ion and the Schiff base improved the inhibition efficiency.

Research topics

  • Corrosion Behavior and Inhibition
  • Concrete Corrosion and Durability
  • Hydrogen embrittlement and corrosion behaviors in metals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1038/s41598-024-51275-5

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.